SABCS 2014: A Bullet Against Breast Cancer Women Aren’t Using
Guest Post by Anees B. Chagpar, MD, MPH, MBA Yale Cancer Center
Tag: Breast cancer
Guest Post by Anees B. Chagpar, MD, MPH, MBA Yale Cancer Center
Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...
SABCS co-chair and AACR President Carlos L. Arteaga, MD, shares his views on this year's symposium and what the...
Research has fueled significant progress against breast cancer—the overall five-year survival rate for female breast cancer patients in the...
In a Los Angeles Times op-ed, Cynthia Ryan, a two-time breast cancer survivor, past participant in the AACR Scientist↔Survivor...
A new study shows big data can be exploited to develop effective breast cancer prevention strategies and the NIH...
Guest Post by Graham A. Colditz, MD, DrPH Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School...
With the easy availability of plentiful, inexpensive, and often unhealthy food, many of us work hard to avoid packing...
The signature pink ribbons of Breast Cancer Awareness Month have become almost as much a part of October as...